Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Hims & Hers Health is set to have a commercial air during Super Bowl LIX. It’s already courting controversy, with calls to ...

Donald Trump’s second administration has advanced an avalanche of policy action and political pronouncements that have jolted ...

The spot makes lofty claims about weight-loss drugs offered by the telehealth company Hims & Hers, but says little about ...

None of the 49 people detained in a raid on a makeshift nightclub in Adams County are facing criminal charges, according to ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

More details on the Canadian plan to boost security at the northern border have been released, as the country tries to navigate the Trump administration's demand to crack down on human and drug ...

A statement from the hospital on Wednesday morning said it could only offer behavioral health services and “supportive care” ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...